Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 8, 2009
Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessmentAlan R Olzinski, Gregory H Turner, Roberta E Bernard, et al.Atherosclerosis|November 5, 2017
Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A2 activity in atherosclerotic plaqueFumiyuki Otsuka, XiaoQing Zhao, Hugh H Trout, et al.Journal of Alzheimer'S Disease : JAD|February 8, 2013
Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladibNimish K Acharya, Eli C Levin, Peter M Clifford, et al.Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidonesHelen F Boyd, Stephen C M Fell, Deirdre M B Hickey, et al.Nature Medicine|September 23, 2008
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque developmentRobert L Wilensky, Yi Shi, Emile R Mohler, et al.Bioorganic & Medicinal Chemistry Letters|March 20, 2003
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2Josie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.Journal of Lipid Research|July 19, 2005
Synthetic LXR agonists increase LDL in CETP speciesPieter H E Groot, Nigel J Pearce, John W Yates, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2002
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.Journal of Medicinal Chemistry|August 19, 2005
Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structureMichael C Jaye, John A Krawiec, Nino Campobasso, et al.Pageof 3